• Rosa María Argüeso-Armesto, Teresa-Rosalia Pérez-Castro, José Luis Díaz-Díaz, Avelino Rodríguez-González, María Eugenia Ameneiros-Lago, Alberto Del Alamo-Alonso, José Manuel de Toro-Santos, Pablo Ángel Fernández-Catalina, Marta Pena-Seijo, Jose Antonio Díaz-Peromingo, Antonio Pose-Reino, Carlos Alberto Názara-Otero, María Rosa Vázquez-Freire, Lisett Escobar-Seoane, Pedro Gordo-Fraile, María Del Mar Castellanos-Rodríguez, José Ángel Rodríguez-Fernández, and Javier Muñiz.
• Servicio Galego de Saúde, Servicio de Endocrinoloxía, Hospital Universitario Lucus Augusti, Lugo, Spain.
• Int. J. Clin. Pract. 2018 Sep 1; 72 (9): e13243.

AimsThere is little information on the familial nature of dyslipidemias in the Spanish population. This knowledge could have potential diagnostic and treatment implications. The objective of the GALIPEMIAS study was to determine the prevalence of familial dyslipidemia in Galicia, as well as determine the degree of lipid control in the participants. Prevalence of atherosclerotic cardiovascular disease (ASCVD) was also estimated. This paper presents the design, methodology and selected preliminary results.MethodologyA cross-sectional study was performed in the population aged ≥18 years using cluster sampling and then random sampling. A sample of 1000 subjects was calculated and divided into three sequential phases with a specific methodology for each one. Phase I: selection of subjects from the general population and collection of informed consent documents; Phase II: collection of data from the digital clinical history to select subjects with dyslipidemia according to study criteria; Phase III: personal interview, blood analysis, family tree, and definitive diagnosis of dyslipidemia. Prevalence of different diseases and active medication was analysed. Corrected prevalence (to the reference population) of different risk factors and ASCVD was estimated.ResultsPhase I participation was 89.5%. We extracted complete information from 93% of the participants (Phase II). According to the study's own criteria, 56.5% (n = 527) of the participants had some form of dyslipidemia and almost 33.7% of them had familial dyslipidemia with autosomal dominant inherit pattern. The corrected prevalence of ASCVD was 5.1% (95% CI 3.1-7.2).ConclusionsDyslipidemia was the most prevalent cardiovascular risk factor in our population with an autosomal dominant inheritance pattern in one out of every three dyslipidemia cases. Approximately, 5.1% of the sample population aged ≥18 has suffered an episode of ACVD.© 2018 John Wiley & Sons Ltd.

16 keywords...

hide…